Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Table 1 Baseline demographics and significant clinical characteristics (n = 200), n (%)
| Variable | Overall (n = 200) | Stage I (n = 68) | Stage II (n = 65) | Stage III (n = 22) | Stage IV (n = 45) | P value |
| Age (years) | 52.9 ± 16.4 | 51.2 ± 15.4 | 54.3 ± 19.3 | 56.1 ± 12.4 | 52.0 ± 15.0 | 0.532 |
| Gender | 0.727 | |||||
| Female | 88 (44.0) | 27 (39.7) | 32 (49.2) | 10 (45.5) | 19 (42.2) | |
| Male | 112 (56.0) | 41 (60.3) | 33 (50.8) | 12 (54.5) | 26 (57.8) | |
| Histological Dx | 0.034a | |||||
| Adenocarcinoma | 129 (64.5) | 43 (63.2) | 38 (58.5) | 20 (90.9) | 28 (62.2) | |
| Others | 71 (35.5) | 25 (36.8) | 27 (41.5) | 2 (9.1) | 17 (37.8) | |
| Histological grade | 0.001b | |||||
| Well | 47 (23.5) | 14 (20.6) | 18 (27.7) | 6 (27.3) | 9 (20.0) | |
| Moderate | 48 (24.0) | 13 (19.1) | 14 (21.5) | 5 (22.7) | 16 (35.6) | |
| Poorly | 47 (23.5) | 9 (13.2) | 14 (21.5) | 10 (45.5) | 14 (31.1) | |
| Atypical | 58 (29.0) | 32 (47.1) | 19 (29.2) | 1 (4.5) | 6 (13.3) | |
| H. pylori (histology) | 0.042a | |||||
| Positive | 130 (65.0) | 36 (52.9) | 48 (73.8) | 17 (77.3) | 29 (64.4) | |
| Negative | 70 (35.0) | 32 (47.1) | 17 (26.2) | 5 (22.7) | 16 (35.6) | |
| Survival status | < 0.001b | |||||
| Deceased | 65 (32.5) | 15 (22.1) | 17 (26.2) | 10 (45.5) | 23 (51.1) | |
| Under treatment | 82 (41.0) | 15 (22.1) | 36 (55.4) | 11 (50.0) | 20 (44.4) | |
| Cured | 53 (26.5) | 38 (55.9) | 12 (18.5) | 1 (4.5) | 2 (4.4) |
- Citation: Mbuthia O, Mahjabeen I, Kayani M, Mehmood A, Obiero J, Matsumoto T, Bosire K, Mureithi M. Helicobacter pylori virulence gene expression defines a stage-associated transcriptional signature in gastric cancer. World J Clin Oncol 2026; 17(10): 125453
- URL: https://www.wjgnet.com/2218-4333/full/v17/i10/125453.htm
- DOI: https://dx.doi.org/10.5306/wjco.125453